Despite the distinct burden of subclonal mutations, some CH mutations were conservative among MM, AL, POEMS, and MGUS, including lymphoid and myeloid CH mutations, such as those in KMT2D, FAT1, MGA, and SYNE1, and myeloma driver genes like ZFHX3 and DIS3. This evidence concerns the gene KMT2D and plasma cell myeloma.